GER-009-06-AVX Early Therapy in Multiple Sclerosis

This study is being done to increase awareness for early therapy with Avonex for Multiple Sclerosis (MS) and the cognitive dysfunction that accompanies MS, and to record safety data for Avonex.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Relapsing-Remitting Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Cognition Disorders Cognitive Dysfunction Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Mental Disorders Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Nervous System Diseases Neurocognitive Disorders

Sex eligibility

All sexes

Study type

Observational

About this study

This study will address the cognitive dysfunction associated with MS. It will track these changes and show that early intervention with Avonex is effective in slowing MS and its effect on patients. Safety data will also be collected during this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

CIS (according to indication) or early Relapsing Remitting Multiple Sclerosis

Exclusion criteria

treatment with DMT during the last 12 months

Sponsors and collaborators

Lead sponsor

Biogen

Industry

Registry information

Acronym: FIT

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2008
First posted: Jun 27, 2007
Registry last updated: Jun 16, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed